U.S. flag

An official website of the United States government

NM_005026.5(PIK3CD):c.1355T>C (p.Leu452Pro) AND Immunodeficiency 14

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Mar 23, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003046688.2

Allele description

NM_005026.5(PIK3CD):c.1355T>C (p.Leu452Pro)

Genes:
LOC126805612:MED14-independent group 3 enhancer GRCh37_chr1:9778914-9780113 [Gene]
PIK3CD:phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p36.22
Genomic location:
Preferred name:
NM_005026.5(PIK3CD):c.1355T>C (p.Leu452Pro)
HGVS:
  • NC_000001.11:g.9720127T>C
  • NG_023434.1:g.73396T>C
  • NG_081936.1:g.1372T>C
  • NG_081936.2:g.1943T>C
  • NM_001350234.2:c.1355T>C
  • NM_001350235.1:c.1268T>C
  • NM_005026.5:c.1355T>CMANE SELECT
  • NP_001337163.1:p.Leu452Pro
  • NP_001337164.1:p.Leu423Pro
  • NP_005017.3:p.Leu452Pro
  • NP_005017.3:p.Leu452Pro
  • LRG_191t1:c.1355T>C
  • LRG_191:g.73396T>C
  • LRG_191p1:p.Leu452Pro
  • NC_000001.10:g.9780185T>C
  • NM_005026.3:c.1355T>C
Protein change:
L423P
Molecular consequence:
  • NM_001350234.2:c.1355T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001350235.1:c.1268T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_005026.5:c.1355T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Immunodeficiency 14 (IMD14A)
Synonyms:
p110-DELTA-ACTIVATING MUTATION CAUSING SENESCENT T CELLS, LYMPHADENOPATHY, AND IMMUNODEFICIENCY; IMMUNODEFICIENCY 14A WITH LYMPHOPROLIFERATION, AUTOSOMAL DOMINANT
Identifiers:
MONDO: MONDO:0014222; MedGen: C3714976; Orphanet: 397596; OMIM: 615513

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV003337823Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))		Uncertain significance
(Mar 23, 2022) 		germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Invitae, SCV003337823.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This variant has not been reported in the literature in individuals affected with PIK3CD-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 452 of the PIK3CD protein (p.Leu452Pro). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024